AdvanDx's 90-minute Staphylococcus tests cleared by FDA
This article was originally published in Clinica
Executive Summary
The US FDA has granted 510(k) clearance for a 90-minute protocol for AdvanDx's S aureus PNA FISH and S aureus/CNS PNA FISH tests. Both tests use fluorescence in situ hybridisation (FISH), the former to detect Staphylococcus aureus bloodstream infections, and the latter to identify coagulase-negative staphylococci (CNS). True S aureus infections can cause life-threatening problems, while blood culture contamination with CNS can lead to a false diagnosis of staphylococcal infection. These patients then receive unnecessary antibiotic treatment. The original tests took 2.5 hours to produce results – the new versions have reduced peptide nucleic acid (PNA) time from 90 to 30 minutes while maintaining high sensitivity and specificity, the Woburn, Massachusetts firm claims.
You may also be interested in...
What are the hottest innovations from Israel?
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
EuroPCR: St Jude and Philips talk up rival intravascular imaging techs
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
EuroPCR: Medtronic's drug-coated balloon keeps rising
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.